Oliver Hatley

Strategies to reduce the risks of mRNA drug and vaccine toxicity

Widespread occurrence of two typical N, N’-substituted p-phenylenediamines and their quinones in humans: Association with oxidative stress and liver damage

Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models

PBPK models for the prediction of in vivo performance of oral dosage forms